Your browser doesn't support javascript.
loading
Significance of Beta Human Chorionic Gonadotropin in Predicting Disease Progression in Uterine Leiomyosarcoma.
Alzibdeh, Abdulla; Mohamad, Issa; Al-Hussaini, Maysa; Salah, Samer; Jaradat, Abdalgani; Abuhijlih, Ramiz; Abuhijla, Fawzi.
Afiliação
  • Alzibdeh A; Department of Radiation Oncology, King Hussein Cancer Center, Amman, Jordan.
  • Mohamad I; Department of Radiation Oncology, King Hussein Cancer Center, Amman, Jordan.
  • Al-Hussaini M; Department of Pathology, King Hussein Cancer Center, Amman, Jordan.
  • Salah S; Department of Medical Oncology, King Hussein Cancer Center, Amman, Jordan.
  • Jaradat A; Faculty of Medicine, The University of Jordan, Amman, Jordan.
  • Abuhijlih R; Department of Radiation Oncology, King Hussein Cancer Center, Amman, Jordan.
  • Abuhijla F; Department of Radiation Oncology, King Hussein Cancer Center, Amman, Jordan.
World J Oncol ; 15(1): 143-148, 2024 Feb.
Article em En | MEDLINE | ID: mdl-38274716
ABSTRACT
Uterine leiomyosarcoma is a high-grade sarcoma that might be associated with dismal outcome. There are no hematological markers that can be used to follow up the recurrence and/or progression of the tumor. We present a case of a 44-year-old female, who was diagnosed with uterine leiomyosarcoma. During her management course, serum beta human chorionic gonadotropin (ß-hCG) elevation was correlated with clinical and radiological disease progression on two separate occasions. This correlation should be further investigated to potentially integrate serum ß-hCG as a predictive tool for clinical behavior and treatment response.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article